Advertisement

Topics

Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients

08:32 EST 1 Dec 2016 | FinanzNachrichten

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) reported positive top-line results of a study that evaluated the use of LYRICA (pregabalin) Capsules CV and Oral Solution CV as adjunctive therapy for p...

Original Article: Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients

NEXT ARTICLE

More From BioPortfolio on "Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...